Heme oxygenase agonists-fluvoxamine, melatonin-are efficacious therapy for Covid-19. | Cell Stress Chaperones;27(1): 3-4, 2022 01. | MEDLINE

Main content 1 Search 2 Footer 3

+A A -A High contrast

WHO COVID-19 Research Database

News/Update/Help

Advanced Search

The WHO Covid-19 Research Database is a resource created in response to the Public Health Emergency of International Concern (PHEIC). Its content remains searchable and spans the time period March 2020 to June 2023. Since June 2023, manual updates to the database have been discontinued.

Heme oxygenase agonists-fluvoxamine, melatonin-are efficacious therapy for Covid-19.

Hooper, Philip L.

Hooper PL; Department of Medicine, Division of Endocrinology and Metabolism, University of Colorado Anschutz Medical Campus, Aurora, CO, USA. phoopermd@gmail.com.

Cell Stress Chaperones ; 27(1): 3-4, 2022 01.

Article in English | MEDLINE | ID: covidwho-1540281

Subject(s)

COVID-19 Drug Treatment; Fluvoxamine/therapeutic use; Heme Oxygenase (Decyclizing)/metabolism; Melatonin/therapeutic use; Humans; SARS-CoV-2/drug effects

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Fluvoxamine / COVID-19 Drug Treatment / Heme Oxygenase (Decyclizing) / Melatonin Limits: Humans Language: English Journal: Cell Stress Chaperones Year: 2022 Document Type: Article Affiliation country: S12192-021-01246-w

Similar

MEDLINE

LILACS

LIS

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Fluvoxamine / COVID-19 Drug Treatment / Heme Oxygenase (Decyclizing) / Melatonin Limits: Humans Language: English Journal: Cell Stress Chaperones Year: 2022 Document Type: Article Affiliation country: S12192-021-01246-w